Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.

Shares of Cencora Inc. COR inched 0.47% higher to $249.97 Wednesday, on what proved to be an all-around favorable trading ...

PharmaLex is now part of Cencora, a leading global pharmaceutical solutions organization centered on improving lives around the world. PharmaLex adds to Cencora’s expanding suite of pharma solutions ...

In a report released yesterday, Steve Baxter from Wells Fargo maintained a Hold rating on Cencora (COR – Research Report), with a price ...

Steve Baxter has given his Hold rating due to a combination of factors that influence Cencora’s current and future performance. The company’s recent financial results showed strong performance ...

CONSHOHOCKEN, Pa. (AP) — CONSHOHOCKEN, Pa. (AP) — Cencora, Inc. (COR) on Wednesday reported fiscal fourth-quarter net income of $3.4 million. On a per-share basis, the Conshohocken ...

For the current fiscal year, Cencora is expected to post earnings of $13.43 per share on $292.23 billion in revenues. This represents a 12.01% change in EPS on a 11.47% change in revenues. For the ...

Cencora, Inc. reported significant growth in its fiscal 2024 results, boasting a 14.7% increase in fourth-quarter revenue to $79.1 billion and a 12.1% rise for the year to $294.0 billion.